Survey on the Effect of Health Related Quality of Life (QOL) Associated With Compliance of Carbocisteine in Asthma Patients
NCT ID: NCT01693471
Last Updated: 2013-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
179 participants
OBSERVATIONAL
2012-09-30
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
NCT02640742
A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test
NCT05634473
The Effect of MK0633 in Patients With Chronic Asthma (0633-007)
NCT00404313
A Cohort Study of Smoking Prevention and Health Promotion for Middle School Students in Wuhan, China
NCT00341653
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)
NCT00636207
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Matters investigated:
1. QOL determination using SF-36 v2
2. Medication compliance (VAS scale)
3. Gender, age, diagnosis, asthma subtype, severity, duration of disease, level of asthma control, concomitant drugs, comorbidities, smoking, alcohol, work
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SEARCH Study Group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Outpatients
* Patients with mild or moderate persistent asthma
* Patients with phlegm
* Patients whose levels of asthma control are partly controlled or uncontrolled
* Patients who are planned to treat MUCODYNE
* Patients who voluntarily submitted written consent forms upon participation in this study
Exclusion Criteria
* Patients with serious cardiac, hepatic, renal, pulmonary, or hematological disease
* Patients with the possibility of pregnancy or suspected pregnancy
* Patients with complication of malignancy
* Current smoker
* Patients with definitive diagnosis for COPD
* Other patients whom investigators or subinvestigators considered inappropriate to participate in this study
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyorin Pharmaceutical Co.,Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Akito Saegusa, Mr.
Role: STUDY_CHAIR
Kyorin Pharmaceutical Co.,Ltd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Senzoku Respiratory Disease and Allergy Clinic
Ōta-ku, Tokyo, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SEARCH-2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.